Published articles

Published articles 1 records found  Search took 0.01 seconds. 
1.
12 p, 2.7 MB Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous / Ungan, Gulnur Semahat (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pons-Escoda, Albert (Institut d'Investigació Biomèdica de Bellvitge) ; Ulinic, Daniel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Ortega-Martorell, Sandra (Liverpool John Moores University. Data Science Research Centre) ; Olier, Iván (Liverpool John Moores University. Data Science Research Centre) ; Vellido, Alfredo (Universitat Politècnica de Catalunya. BarcelonaTech) ; Majos, Carles (Institut d'Investigació Biomèdica de Bellvitge) ; Julià Sapé, Ma. Margarita (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow-up study to evaluate treatment response is performed 1 month after concomitant treatment, when contrast-enhancing regions may appear that can correspond to true progression or pseudoprogression. [...]
2024 - 10.1002/nbm.5095
NMR in Biomedicine, (January 2024) , Art. e5095
2 documents

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.